Nivolumab as second-line treatment and beyond for metastatic renal cell carcinoma: A real-life experience from Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database.
Year: 2021
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Emre Yekeduz, Ismail Erturk, Deniz Tural, Nuri Karadurmus, Serdar Karakaya, Mutlu Hizal, Çağatay Arslan, Hakan Taban, Ahmet Küçükarda, Nihan Şentürk Öztaş, Ozlem Nuray Sever, Gokhan Uçar, Mehmet Ali Nahit Sendur, Umut Demirci, Saadettin Kilickap, Irfan Cicin, Berna Oksuzoglu, Mustafa Ozguroglu, Yuksel Urun
Institutions: Ankara University, Sağlık Bilimleri Üniversitesi, Bakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi, Ankara Onkoloji Eğitim ve Araştırma Hastanesi, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Bahçeşehir University, Hacettepe University, Trakya University, Istanbul University-Cerrahpaşa, Gaziantep University, Üsküdar University, Memorial Ankara Hospital, Istanbul University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3135423014
